EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Neuroprotective and Anti-inflammatory Dual-Phenotypic Drug Screening Strategies

Xue-Hui Liu, Hong-Yuan Liu iD, Jing Gu, Mouxin Huang iD, Qin Ouyang iD

ACS Chemical Neuroscience · 07.05.2025 · 16 (9) · 1631-1633

DOI: 10.1021/acschemneuro.5c00123 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ACS Chemical Neuroscience, online erschienen am 10.04.2025. Verfasst von Xue-Hui Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, Third Military Medical University, Chongqing 400038, China. Hauptthemen laut MEDLINE: Neuroprotective Agents, Anti-Inflammatory Agents, Reperfusion Injury. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 5 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Chongqing Youth Innovation Talent Program, Outstanding Youth Fund of Chongqing.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Traditional drug development, which predominantly focuses on single target/phenotype evaluation, often fails to achieve optimal therapeutic outcomes in multifactorial and multitarget conditions like ischemia-reperfusion injury. In this viewpoint, we highlight a novel dual-phenotypic drug screening strategy targeting neuronal protective and anti-inflammatory effects for treatment of ischemia-reperfusion injury. This strategy involves the utilization of primary neuron treated with oxygen-glucose deprivation/reoxygenation (OGD/R), lipopolysaccharide (LPS)-activated microglial models and coculture systems or brain organoids as in vitro models, as well as mouse middle cerebral artery occlusion/reperfusion (MCAO/R) models for in vivo evaluation. The dual-phenotypic drug screening strategies marks a paradigm shift from single-factorial approach to a system biology-based integrated methodology, offering significant advantages for developing therapies for the complex multifactorial disease ischemia-reperfusion injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroprotective AgentsAnti-Inflammatory AgentsReperfusion InjuryAnimalsHumansDrug Evaluation, PreclinicalNeuronsMiceMicrogliaPhenotype

Stichwörter der Autor:innen

anti-inflammatorydual-phenotypic drug screening strategyischemia-reperfusion injuryischemic strokeneuronal protection

Substanzen

Neuroprotective AgentsAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Department of Medicinal Chemistry, Third Military Medical University, Chongqing 400038, China.

ORCID-Profile: Hong-Yuan Liu, Mouxin Huang, Qin Ouyang

Förderung

  • National Natural Science Foundation of China
  • Chongqing Youth Innovation Talent Program
  • Outstanding Youth Fund of Chongqing

Zitieren

APA

Liu, X. H., Liu, H. Y., Gu, J., Huang, M., & Ouyang, Q. (2025). Neuroprotective and Anti-inflammatory Dual-Phenotypic Drug Screening Strategies. ACS Chemical Neuroscience, 16(9), 1631-1633. https://doi.org/10.1021/acschemneuro.5c00123

Vancouver

Liu XH, Liu HY, Gu J, Huang M, Ouyang Q. Neuroprotective and Anti-inflammatory Dual-Phenotypic Drug Screening Strategies. ACS Chemical Neuroscience. 2025;16(9):1631-1633. doi:10.1021/acschemneuro.5c00123

BibTeX
@article{Liu2025,
  author = {Liu, Xue-Hui and Liu, Hong-Yuan and Gu, Jing and Huang, Mouxin and Ouyang, Qin},
  title = {Neuroprotective and Anti-inflammatory Dual-Phenotypic Drug Screening Strategies},
  journal = {ACS Chemical Neuroscience},
  year = {2025},
  volume = {16},
  number = {9},
  pages = {1631--1633},
  doi = {10.1021/acschemneuro.5c00123}
}
Kostenlos starten →